Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Multicentric Castleman's disease associated with rheumatoid arthritis: a possible role of hepatitis B antigen.

Literature DB >> 2712614

Multicentric Castleman's disease associated with rheumatoid arthritis: a possible role of hepatitis B antigen.

E Ben-Chetrit¹, D Flusser, E Okon, Z Ackerman, A Rubinow.

Abstract

A patient with seropositive rheumatoid arthritis and a carrier of hepatitis B surface antigen developed angiofollicular hyperplasia (multicentric Castleman's disease). The hepatitis B virus and the rheumatoid factor may have had a role in the aetiology of this lymphatic disorder. The development of Castleman's disease in association with these factors may provide another clue supporting the reactive nature of this disease.

Entities: Disease Species

Mesh：

Substances：

Year: 1989 PMID： 2712614 PMCID： PMC1003750 DOI： 10.1136/ard.48.4.326

Source DB: PubMed Journal: Ann Rheum Dis ISSN： 0003-4967 Impact factor: 19.103

13 in total

1. Protein measurement with the Folin phenol reagent.

Authors: O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal: J Biol Chem Date: 1951-11 Impact factor: 5.157

2. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations.

Authors: A R Keller; L Hochholzer; B Castleman
Journal: Cancer Date: 1972-03 Impact factor: 6.860

3. Castleman's disease: more questions than answers.

Authors: G Frizzera
Journal: Hum Pathol Date: 1985-03 Impact factor: 3.466

4. Multicentric Castleman's disease and Kaposi's sarcoma.

Authors: K T Chen
Journal: Am J Surg Pathol Date: 1984-04 Impact factor: 6.394

5. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 32-1984. An elderly man with progressive neuropathy and elevated gamma globulin.

Authors:
Journal: N Engl J Med Date: 1984-08-09 Impact factor: 91.245

6. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease. Pathological findings in 15 patients.

Authors: G Frizzera; P M Banks; G Massarelli; J Rosai
Journal: Am J Surg Pathol Date: 1983-04 Impact factor: 6.394

7. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients.

Authors: G Frizzera; B A Peterson; E D Bayrd; A Goldman
Journal: J Clin Oncol Date: 1985-09 Impact factor: 44.544

8. Atypical hyperplasia of lymph nodes: a follow-up study.

Authors: K R Schroer; K O Franssila
Journal: Cancer Date: 1979-09 Impact factor: 6.860

9. Development of a novel C1q immunoadsorbent for removal of circulating immunecomplexes: quantitative isolation of hepatitis B virus surface antigen and immunecomplexes.

Authors: Y Gazitt; S Margel; A Lerner; J R Wands; D Shouval
Journal: Immunol Lett Date: 1985 Impact factor: 3.685

7. Development of severe thrombocytopenia with TAFRO syndrome-like features in a patient with rheumatoid arthritis treated with a Janus kinase inhibitor: A case report.

Authors: Keiichiro Kadoba; Daisuke Waki; Keisuke Nishimura; Hiroki Mukoyama; Rintaro Saito; Hiroyuki Murabe; Toshihiko Yokota
Journal: Medicine (Baltimore) Date: 2020-10-16 Impact factor: 1.817

7 in total

Multicentric Castleman's disease associated with rheumatoid arthritis: a possible role of hepatitis B antigen.

1. Protein measurement with the Folin phenol reagent.

2. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations.

3. Castleman's disease: more questions than answers.

4. Multicentric Castleman's disease and Kaposi's sarcoma.

5. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 32-1984. An elderly man with progressive neuropathy and elevated gamma globulin.

6. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease. Pathological findings in 15 patients.

7. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients.

8. Atypical hyperplasia of lymph nodes: a follow-up study.

9. Development of a novel C1q immunoadsorbent for removal of circulating immunecomplexes: quantitative isolation of hepatitis B virus surface antigen and immunecomplexes.

10. Multicentric giant lymph node hyperplasia.

1. Lymphoid hyperplasia of the thymus showing Castleman's disease in a patient with myasthenia gravis.

2. Giant lymph node hyperplasia (Castleman's disease): a clinical study of eight patients.

3. Multicentric Castleman's disease in a patient with primary Sjögren's syndrome.

4. A case of Takayasu arteritis complicated by Castleman's disease.

5. Clinical characteristics and immunological abnormalities of Castleman disease complicated with autoimmune diseases.

6. Historical and pathological overview of Castleman disease.

7. Development of severe thrombocytopenia with TAFRO syndrome-like features in a patient with rheumatoid arthritis treated with a Janus kinase inhibitor: A case report.